Biotech Industry Forms International Council

News
Article

New International Council on Biotechnology Associations advocates biotechnology growth.

The Biotechnology Industry Organization (BIO) is reporting that an international confederation of biotechnology trade associations has created the International Council on Biotechnology Associations (ICBA) to advocate for public policies that support worldwide biotechnology growth. BIO’s president and CEO, Jim Greenwood, has been elected to serve as ICBA Chairman, and Nathalie Moll, secretary general of EuropaBio, was elected Vice Chair.

“The increasingly global biotechnology industry provides breakthrough products and technologies that combat debilitating and rare diseases, reduce our environmental footprint, feed the hungry, use less and cleaner energy, and have safer, cleaner and more efficient industrial manufacturing processes,” said Greenwood in a press release. “However, the biotechnology sector faces both challenges and opportunities that cross borders.  In forming the ICBA, our industry is taking an important step that allows us to better coordinate, organize and face these issues around the world together."

“Biotechnology is geared at enhancing our quality of life and responding to society’s grand challenges such as an ageing and ever increasing population, healthcare choice and affordability, resource efficiency, food security, climate change, energy shortages and economic growth,” said Moll in the press release. “The ICBA will advocate for more efficient and effective governance, science-based regulatory systems and the right framework conditions for competitiveness and innovation to ensure faster and more equitable access to biotech products and processes for patients, farmers and consumers around the world.”

Source:

BIO.org

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content